BioInfra Life Science Inc. (XKON: 266470)
South Korea flag South Korea · Delayed Price · Currency is KRW
350.00
-14.00 (-3.85%)
Dec 20, 2024, 9:00 AM KST

BioInfra Life Science Company Description

BIOINFRA Life Science Inc., a healthcare company, develops cancer gene treatments and technologies that monitor the possibility of metastasis and recurrence in blood for cancer patients in South Korea.

Its portfolio includes cancer screening test technology, cancer biomarker research, in-vitro diagnostics medical devices, and targeted drug delivery systems for cancer treatment.

The company was founded in 2001 and is based in Seoul, South Korea.

BioInfra Life Science Inc.
Country South Korea
Industry Surgical and Medical Instruments and Apparatus
CEO Dukyun Lee

Contact Details

Address:
Daehak-ro 49
Seoul, 03127
South Korea
Phone 82 2 6012 0333
Website bioinfra.co.kr

Stock Details

Ticker Symbol 266470
Exchange Korea New Exchange
Fiscal Year January - December
Reporting Currency KRW
SIC Code 3841

Key Executives

Name Position
Dukyun Lee Chief Executive Officer